copy & paste directly from Argus,
Medtronic is one of the world's largest medical technology and solutions companies. The company’s devices focus on cardiac rhythm management, spinal and surgical navigation technologies, treatments
for diabetes and neurological conditions, vascular therapies, and cardiac surgery. MDT has been a poor performer versus the S&P 500 and Healthcare sector since April 2020, after nice outperformance versus the SPX from mid-2012 to mid-2016. The stock had a nice run from 6/2012 until its latest peak in 8/2021. The shares then were smacked to $75 in 11/2022 from $129.
MDT traced out a double bottom and broke out on April 24 with huge volume after FDA approval of the company’s diabetes device. After that, the stock moved to $91 and close to its August 2022
high. The shares then were hit again, falling back to $81. We have seen a nice bullish reversal after MDT bounced off its 200-day.
Chart and moving-average support are at $82 and we would put a stoploss just below there. We would take profits at $100, with larger longterm gains possible.
Medtronic is one of the world's largest medical technology and solutions companies. The company’s devices focus on cardiac rhythm management, spinal and surgical navigation technologies, treatments
for diabetes and neurological conditions, vascular therapies, and cardiac surgery. MDT has been a poor performer versus the S&P 500 and Healthcare sector since April 2020, after nice outperformance versus the SPX from mid-2012 to mid-2016. The stock had a nice run from 6/2012 until its latest peak in 8/2021. The shares then were smacked to $75 in 11/2022 from $129.
MDT traced out a double bottom and broke out on April 24 with huge volume after FDA approval of the company’s diabetes device. After that, the stock moved to $91 and close to its August 2022
high. The shares then were hit again, falling back to $81. We have seen a nice bullish reversal after MDT bounced off its 200-day.
Chart and moving-average support are at $82 and we would put a stoploss just below there. We would take profits at $100, with larger longterm gains possible.
Comment:
trade it with 90c exp 09.15 into its earning
